Nitrazolam
A benzodiazepine derivative
Nitrazolam | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Nitrazolam is a benzodiazepine derivative that is known for its potent anxiolytic, sedative, and hypnotic properties. It is a psychoactive substance that acts on the central nervous system by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA_A receptor.
Pharmacology[edit | edit source]
Nitrazolam, like other benzodiazepines, works by binding to the benzodiazepine site on the GABA_A receptor. This binding increases the frequency of chloride ion channel opening, leading to hyperpolarization of the neuron and a decrease in neuronal excitability. The result is a calming effect on the brain, which accounts for its use in treating anxiety disorders, insomnia, and other conditions.
Chemical Structure[edit | edit source]
Nitrazolam is chemically related to other benzodiazepines, sharing a core structure that includes a diazepine ring fused to a benzene ring. The presence of a nitro group at the 7-position of the diazepine ring is a distinguishing feature of nitrazolam, contributing to its pharmacological profile.
Clinical Use[edit | edit source]
While nitrazolam is not widely used in clinical practice, it has been studied for its potential applications in treating severe anxiety and sleep disorders. Its high potency means that it is effective at low doses, but this also increases the risk of adverse effects and dependence.
Adverse Effects[edit | edit source]
Common side effects of nitrazolam include drowsiness, dizziness, and muscle weakness. More serious effects can include respiratory depression, especially when combined with other central nervous system depressants such as alcohol or opioids. Long-term use can lead to tolerance, dependence, and withdrawal syndrome.
Legal Status[edit | edit source]
The legal status of nitrazolam varies by country. In some jurisdictions, it is classified as a controlled substance due to its potential for abuse and dependence. It is important for healthcare providers to be aware of the legal regulations regarding nitrazolam in their region.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD